KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

DEPAKIN SYRUP

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

 

GENERIC NAME:

VALPROIC ACID

 

MANUFACTURER:

SANOFI WINTHROP

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

D

 

INDICATIONS:

Seizures, absence

Seizures, complex partial

 

SIDE EFFECTS:

nausea and vomiting

trembling of hands and arms

unusual weight loss or gain

Ataxia

constipation

dizziness

drowsiness

headache

skin rash

unusual excitement, restlessness, or irritability

Behavioral, mood, or mental changes

hepatotoxicity or hyperammonemia

ophthalmological effects, specifically diplopia

nystagmus

spots before eyes

pancreatitis

platelet aggregation inhibition or thrombocytopenia

Abdominal or stomach cramps, mild

anorexia

change in menstrual periods

diarrhea

hair loss

indigestion

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Blood dyscrasias

Brain disease,

Hepatic disease

Hypoalbuminemia

Renal function impairment

 

ADULT DOSE:

Anticonvulsant- Monotherapy: Oral, initially, 5 to 15 mg per kg of body weight a day, the dosage being increased at one-week intervals by 5 to 10 mg per kg of body weight a day as needed and tolerated. Polytherapy: Oral, initially, 10 to 30 mg per kg of body weight a day, the dosage being increased at one-week intervals by 5 to 10 mg per kg of body weight a day as needed and tolerated. Note: If the total daily dose exceeds 250 mg, it should be divided into two or more doses (usually given every 12 hours ) to lessen the possibility of gastrointestinal irritation. Geriatric patients may need lower doses. Patients also taking a hepatic enzyme-inducing medication may need higher dosages depending on predose serum concentrations.

 

MAXIMUM ADULT DOSE:

60 mg per kg of body weight a day.

 

PEDIATRIC DOSE:

Anticonvulsant-Children 1 to 12 years of age- Monotherapy: Oral, initially, 15 to 45 mg per kg of body weight a day, the dosage being increased at one-week intervals by 5 to 10 mg per kg of body weight a day as needed and tolerated. Polytherapy: Oral, 30 to 100 mg per kg of body weight a day. Note: Dosage adjustments depend on clinical response and serum anticonvulsant concentrations. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

Geriatric patients may need lower doses . See Usual adult and adolescent dose .

 

 

PREVIOUS

  

NEXT